EGFR and central nervous system cancer: At 5 days following implantation of 500,000 U87 human glioma cells in the caudate-putamen, mice were treated weekly by IV administration of (a) saline or (b) 5 μg DNA per mouse of HIRMAb/TfRMAb-THLs encapsulating the anti-EGFR shRNA expression plasmid.